Clin Nutr Res.  2019 Apr;8(2):138-147. 10.7762/cnr.2019.8.2.138.

Effects of Bread with Nigella Sativa on Blood Glucose, Blood Pressure and Anthropometric Indices in Patients with Metabolic Syndrome

• Mohtashami A

• KMID: 2444230
• DOI: http://doi.org/10.7762/cnr.2019.8.2.138

Abstract

Nigella sativa (N. sativa) is one of important herbal foods in traditional medicine and many studies have conducted to show the effects of this plant on several diseases. The goal of this study was the evaluation of effects of bread with N. Sativa on clinical parameters such as blood glucose, blood pressure (BP) and anthropometry indices in subjects with metabolic syndrome (MetS). A study as double-blind, cross-over, randomized clinical trial was performed in 51 MetS patients in Chalus, north region of Iran. After dividing of patients randomly in 2 groups, in phase 1, intervention group (A, n = 27) used daily a bread with N. sativa and control group (B, n = 24) used the same bread but without N. sativa for 2 months. After considering of 15 day wash out period, phase 2 was began with changing of position of 2 groups. Measuring of parameters including fasting blood glucose (FBG), systolic blood pressure (SBP), diastolic blood pressure (DBP), weight, body mass index (BMI), and waist circumference (WC) was done before and after of 2 phases. After evaluation of treatment, sequence and time effects of intervention on parameters, it is shown that consumption of this bread has not significant treatment effect (as main effect) on FBG, SBP, DBP, WC, weight, and BMI (p > 0.05). Sequence effect on FBG, weight, WC, and BMI was significant (p < 0.05), but was not on BP. Time effect was only significant for DBP. Consumption of bread with N. sativa in MetS patients has not significant effect on FBG, BP, weight, WC, and BMI. TRIAL REGISTRATION: Iranian Registry of Clinical Trials Identifier: IRCT2015041821815N1

Keyword

Nigella sativa; Blood glucose; Blood pressure; Anthropometry indices; Metabolic syndrome

MeSH Terms

Anthropometry
Blood Glucose*
Blood Pressure*
Body Weight
Bread*
Fasting
Humans
Iran
Medicine, Traditional
Nigella sativa*
Nigella*
Plants
Waist Circumference
Blood Glucose

Figure

• 

  Figure 1 CONSORT flow diagram.

Reference

1. Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol. 2008; 61:697–706.

2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988; 37:1595–1607.

3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–2752.

4. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49:403–414.

5. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino RB Jr, Wagenknecht LE, Haffner SM. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005; 112:3713–3721.

6. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007; 86:s836–s842.

7. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007; 77:251–257.

8. Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009; 2009:136501.

9. Karimi F, Jahandideh D, Dabbaghmanesh MH, Fattahi MR, Ranjbar Omrani GH. The prevalence of metabolic syndrome and its components among adults in a rural community, Fars, Iran. Int Cardiovasc Res J. 2015; 9:94–99.

10. Maleki F, Sayehmiri F, Kiani F, Sayehmiri K, Nasiri S. Metabolic syndrome prevalence in Iran: a systematic review and meta-analysis. J Kermanshah Univ Med Sci. 2014; 18:e74115.

11. Vimaleswaran KS, Radha V, Mohan V. Thr54 allele carriers of the Ala54Thr variant of FABP2 gene have associations with metabolic syndrome and hypertriglyceridemia in urban South Indians. Metabolism. 2006; 55:1222–1226.

12. Mohan V, Gokulakrishnan K, Deepa R, Shanthirani CS, Datta M. Association of physical inactivity with components of metabolic syndrome and coronary artery disease--the Chennai Urban Population Study (CUPS no. 15). Diabet Med. 2005; 22:1206–1211.

13. Hasani-Ranjbar S, Larijani B, Abdollahi M. A systematic review of Iranian medicinal plants useful in diabetes mellitus. Arch Med Sci. 2008; 4:285–292.

14. Sayed MD. Traditional medicine in health care. J Ethnopharmacol. 1980; 2:19–22.

15. Shrivastava RM, Agrawal RC, Parveen ZJ. A review on therapeutic applications of Nigella sativa. J Chem Chem Sci. 2011; 1:241–248.

16. Khoddami A, Ghazali HM, Yassoralipour A, Ramakrishnan Y, Ganjloo A. Physicochemical characteristics of nigella seed (Nigella sativa L.) oil as affected by different extraction methods. J Am Oil Chem Soc. 2011; 88:533–540.

17. Sabzghabaee AM, Dianatkhah M, Sarrafzadegan N, Asgary S, Ghannadi A. Clinical evaluation of Nigella sativa seeds for the treatment of hyperlipidemia: a randomized, placebo controlled clinical trial. Med Arh. 2012; 66:198–200.

18. Najmi A, Nasiruddin M, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev Ctries. 2008; 28:11–14.

19. Najmi A, Nsiruddin M, Khan RA, Haque SF. Indigenous herbal product Nigella sativa proved effective as an antihypertensive in metabolic syndrome. Asian J Pharm Clin Res. 2013; 6:61–64.

20. Ibrahim RM, Hamdan NS, Ismail M, Saini SM, Abd Rashid SN, Abd Latiff L, Mahmud R. Protective effects of Nigella sativa on metabolic syndrome in menopausal women. Adv Pharm Bull. 2014; 4:29–33.

21. Datau EA, Wardhana , Surachmanto EE, Pandelaki K, Langi JA, Fias . Efficacy of Nigella sativa on serum free testosterone and metabolic disturbances in central obese male. Acta Med Indones. 2010; 42:130–134.

22. Haque SH, Nasiruddin M, Najmi A. Indigenous herbal product Nigella sativa proved effective as an anti-obesity therapy in metabolic syndrome. Int J Medicobiol Res. 2011; 1:173–176.

23. Mahan LK, Escott-Stump S, Raymond JL. Krause's food and the nutrition care process. 13th ed. St. Louis (MO): Elsevier/Saunders;2012.

24. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care. 2005; 28:2823–2831.

25. Husseini MS, Mirkarimi SA, Amini M, Mohtashami R, Kianbakht S, Fallah Hoseini H. Effects of Nigella sativa L. seed oil in type II diabetic patients: a randomized, double-blind, placebo-controlled clinical trial. J Med Plants. 2013; 12:93–99.

26. Najmi A, Haque S, Khan R, Nasiruddin M. Therapeutic effect of Nigella Sativa oil on clinical and biochemical parameters in metabolic syndrome. Int J Pharmacol. 2007; 5:13.

27. Geng D, Zhang S, Lan J. Analysis on chemical components of volatile oil and determination of thymoquinone from seed of Nigella glandulifera. Zhongguo Zhongyao Zazhi. 2009; 34:2887–2890.

28. Meddah B, Ducroc R, El Abbes Faouzi M, Eto B, Mahraoui L, Benhaddou-Andaloussi A, Martineau LC, Cherrah Y, Haddad PS. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J Ethnopharmacol. 2009; 121:419–424.

29. Toppozada HH, Mazloum HA, el-Dakhakhny M. The antibacterial properties of the Nigella sativa l. seeds. Active principle with some clinical applications. J Egypt Med Assoc. 1965; 48:Suppl. 187–202.

30. Shah AS, Khan GM, Badshah A, Shah SU, Shah KU, Mirza SA, Shah KU, Khan KA. Nigella sativa provides protection against metabolic syndrome. Afr J Biotechnol. 2012; 11:10919–10925.

31. Fallah Huseini H, Amini M, Mohtashami R, Ghamarchehre ME, Sadeqhi Z, Kianbakht S, Fallah Huseini A. Blood pressure lowering effect of Nigella sativa L. seed oil in healthy volunteers: a randomized, double-blind, placebo-controlled clinical trial. Phytother Res. 2013; 27:1849–1853.

32. Dehkordi FR, Kamkhah AF. Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension. Fundam Clin Pharmacol. 2008; 22:447–452.

33. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 2006; 54:229–234.

34. Terés S, Barceló-Coblijn G, Benet M, Alvarez R, Bressani R, Halver JE, Escribá PV. Oleic acid content is responsible for the reduction in blood pressure induced by olive oil. Proc Natl Acad Sci U S A. 2008; 105:13811–13816.